MLchartDataset catalogue

Petadeferitrin

Term · Oncology and biomedicine · MLC-T-ONC-015994

An orally bioavailable iron-chelating agent and derivative of desferrithiocin, with iron chelating and protective activities in diseases of iron overload. Upon oral administration, petadeferitrin targets, binds to and chelates free iron. This induces the excretion of iron, prevents iron accumulation and prevents cellular and/or tissue damage associated with iron overload.

Table 1. Record
IdentifierMLC-T-ONC-015994
FieldOncology and biomedicine
Synonymschelating agent SP-420; iron chelating agent SP-420; iron chelator SP-420
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015994",
  "term": "Petadeferitrin",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable iron-chelating agent and derivative of desferrithiocin, with iron chelating and protective activities in diseases of iron overload. Upon oral administration, petadeferitrin targets, binds to and chelates free iron. This induces the excretion of iron, prevents iron accumulation and prevents cellular and/or tissue damage associated with iron overload.",
  "synonyms": [
    "chelating agent SP-420",
    "iron chelating agent SP-420",
    "iron chelator SP-420"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/petadeferitrin/"
}

Record 13,036 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.